Factors associated with foreign body infection in methicillin-resistant Staphylococcus aureus bacteremia

被引:1
|
作者
Bouiller, Kevin [1 ,2 ]
Jacko, Natasia F. [1 ]
Shumaker, Margot J. [1 ]
Talbot, Brooke M. [3 ]
Read, Timothy D. [3 ]
David, Michael Z. [1 ]
机构
[1] Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA
[2] Univ Franche Comte, CHU Besancon, Dept Infect & Trop Dis, UMR CNRS 6249 Chrono Environm, Besancon, France
[3] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
Staphylococcus aureus; biofilm; foreign bodies; methicillin resistance; bacteremia; EUROPEAN ASSOCIATION; CASE-DEFINITION; BIOFILM; COLLABORATION; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS; DISEASES; SOCIETY; PLATES;
D O I
10.3389/fimmu.2024.1335867
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: We aimed to compare patient characteristics, MRSA sequence types, and biofilm production of MRSA strains that did and did not cause a foreign body infection in patients with MRSA bloodstream infections (BSI) Methods: All adult patients with MRSA BSI hospitalized in two hospitals were identified by clinical microbiology laboratory surveillance. Only patients who had at least one implanted foreign body during the episode of BSI were included. Results: In July 2018 - March 2022, of 423 patients identified with MRSA BSI, 118 (28%) had >= 1 foreign body. Among them, 51 (43%) had one or more foreign body infections. In multivariable analysis, factors associated with foreign body infection were history of MRSA infection in the last year (OR=4.7 [1.4-15.5], p=0.012) community-associated BSI (OR=68.1 [4.2-1114.3], p=0.003); surgical site infection as source of infection (OR=11.8 [2-70.4], p=0.007); presence of more than one foreign body (OR=3.4 [1.1-10.7], p=0.033); interval between foreign body implantation and infection <18 months (OR=3.3 [1.1-10], p=0.031); and positive blood culture >= 48h (OR=16.7 [4.3-65.7], p<0.001). The most prevalent sequence type was ST8 (39%), followed by ST5 (29%), and ST105 (20%) with no significant difference between patients with or without foreign body infection. Only 39% of MRSA isolates formed a moderate/strong biofilm. No significant difference was observed between patients with foreign body infection and those without foreign body infection. In multivariable analysis, subjects infected with a MRSA isolate producing moderate/strong in vitro biofilm were more likely to have a history of MRSA infection in the last year (OR=3.41 [1.23-9.43]), interval between foreign body implantation and MRSA BSI <18 months (OR=3.1 [1.05-9.2]) and ST8 (OR=10.64 [2-57.3]). Conclusion: Most factors associated with foreign body infection in MRSA BSI were also characteristic of persistent infections. Biofilm-forming isolates were not associated with a higher risk of foreign-body infection but appeared to be associated with MRSA genetic lineage, especially ST8.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients
    Kan, Li-Ping
    Lin, Jung-Chung
    Chiu, Sheng-Kang
    Yeh, Yen-Cheng
    Lin, Te-Yu
    Yang, Ya-Sung
    Wang, Yung-Chih
    Wang, Ning-Chi
    Yeh, Kuo-Ming
    Chang, Feng-Yee
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2014, 47 (01) : 15 - 22
  • [42] Linezolid Utilization in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
    Caffrey, Aisling R.
    Gupta, Kalpana
    Quilliam, Brian J.
    Friedmann, Peter D.
    LaPlante, Kerry L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S185 - S185
  • [43] Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan
    Isobe, Masaaki
    Uejima, Etsuko
    Seki, Masafumi
    Yamagishi, Yoshiaki
    Miyawaki, Koji
    Yabuno, Kaori
    Masaoka, Mari
    Hamaguchi, Shigeto
    Yoshioka, Nori
    Tomono, Kazunori
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (06) : 841 - 847
  • [44] Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia in Gaborone, Botswana
    Wood, Sarah M.
    Shah, Samir S.
    Bafana, Margaret
    Ratner, Adam J.
    Meaney, Peter A.
    Malefho, Kolaatamo C. S.
    Steenhoff, Andrew P.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (08): : 782 - 785
  • [45] SOURCES AND OUTCOME FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS BACTEREMIA
    CAFFERKEY, MT
    HONE, R
    KEANE, CT
    JOURNAL OF HOSPITAL INFECTION, 1988, 11 (02) : 136 - 143
  • [46] Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia
    McCalla, Carlo
    Smyth, Davida S.
    Robinson, D. Ashley
    Steenbergen, Judith
    Luperchio, Steven A.
    Moise, Pamela A.
    Fowler, Vance G., Jr.
    Sakoulas, George
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (09) : 3441 - 3443
  • [47] Updates on Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia
    Alison L. Blackman
    Ellen C. Rubin
    Eleanor K. Broadbent
    Karrine D. Brade
    Current Infectious Disease Reports, 2020, 22
  • [48] Methicillin-resistant Staphylococcus aureus bacteremia carrying the mecC gene
    Garcia, Irati Arregui
    Portillo, M. Eugenia
    Alvarez, Luis Torroba
    Baquedano, Carmen Ezpeleta
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2023, 41 (07): : 446 - 447
  • [49] Methicillin-resistant staphylococcus aureus bacteremia due to prostatic abscess
    Chao, B. H.
    Kidd, J. M.
    Dow, A. W.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 153 - 154
  • [50] Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus
    Vaudaux, P
    Gjinovci, A
    Bento, M
    Li, DM
    Schrenzel, J
    Lew, DP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (09) : 3789 - 3793